7月16日，联合健康盘中上涨超9%，报456美元/股，成交额超13亿美元。
消息面上，公司盘前发布第二季度财报，业绩全面超出市场预期。调整后每股收益6.38美元，大幅超出市场一致预期的4.86美元，同比增长56.37%；营收1120.32亿美元，高于预期的1108亿美元。同时，公司将全年调整后每股收益指引从此前的18.25美元以上大幅上调至19.50至20.00美元，远超市场预估的18.49美元。
业绩超预期主要得益于有效的成本控制与运营优化，管理层表示联邦医疗保险成本增速将低于此前约10%的预估水平。此外，公司规划全年至少回购50亿美元股票，全年经营现金流预期240亿美元，财务结构稳健。板块同业哈门那涨2.17%，Molina Healthcare涨1.34%，整体情绪受提振。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
